Cargando…
Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer
Tyrosine kinase receptor TIE-1 plays a critical role in angiogenesis and blood-vessel stability. In recent years, increased TIE-1 expression has been observed in many types of cancers; however, the biological significance and underlying mechanisms remain unknown. Thus, in the present study, we inves...
Autores principales: | Zhang, Xuewei, Ishibashi, Masumi, Kitatani, Kazuyuki, Shigeta, Shogo, Tokunaga, Hideki, Toyoshima, Masafumi, Shimada, Muneaki, Yaegashi, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352248/ https://www.ncbi.nlm.nih.gov/pubmed/32604863 http://dx.doi.org/10.3390/cancers12061705 |
Ejemplares similares
-
Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer
por: Ishibashi, Masumi, et al.
Publicado: (2018) -
Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers
por: Hasegawa-Minato, Junko, et al.
Publicado: (2017) -
CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents
por: Oyama, Yoshiko, et al.
Publicado: (2021) -
Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid
por: Kitatani, Kazuyuki, et al.
Publicado: (2015) -
Diagnostic Performance of Preoperative Imaging in Endometrial Cancer
por: Hashimoto, Chiaki, et al.
Publicado: (2023)